TipRanks
Go Ultimate55% OFF

Irit Arbel Insider Profile

4 Followers

Irit Arbel, Director at Brainstorm Cell Therapeutics, holds 161.05K shares in Brainstorm Cell Therapeutics (Ticker: BCLI), holds 0.00 shares in Pluri (Ticker: PLUR).

Irit Arbel's Trading History

BCLI
Brainstorm Cell Therapeutics
May 29, 2026DirectorUninformative Buy―$154.13K
PLUR
Pluri
―CEO, Director―$0.00

You May Also Like

Irit Arbel insider profile FAQ

What is the percentage of profitable transactions made by Irit Arbel?
The percentage of profitable transactions made by Irit Arbel is 0%.
What is the average return per transaction made by Irit Arbel?
The average return per transaction made by Irit Arbel is -121.60%.
What stocks does Irit Arbel hold?
Irit Arbel holds: BCLI, PLUR stocks.
What was Irit Arbel's most profitable transaction?
Irit Arbel’s most profitable transaction was an Informative Buy of BCLI stock on August 31, 2017. The return on the trade was -7.00%.
What is Irit Arbel's role in Brainstorm Cell Therapeutics?
Irit Arbel's role in Brainstorm Cell Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.